APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Prostacyclin (PGI2) ELISA Kits

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Prostacyclin (PGI2) ELISA Kits Market Outlook and Growth Opportunities 2026

Report ID 174029300421 December 2025191 pages

Choose your research edition.

Industry ResearchProstacyclin (PGI2) ELISA Kits Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Prostacyclin (PGI2) ELISA Kits Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Prostacyclin (PGI2) ELISA Kits Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Prostacyclin (PGI2) ELISA Kits Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Prostacyclin (PGI2) ELISA Kits Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Prostacyclin (PGI2) ELISA Kits market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Prostacyclin (PGI2) ELISA Kits is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Prostacyclin (PGI2) ELISA Kits is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Prostacyclin (PGI2) ELISA Kits is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Prostacyclin (PGI2) ELISA Kits market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Prostacyclin (PGI2) ELISA Kits market include United States Biological, Fitzgerald Industries International, Enzo Life Sciences, Biomatik Corporation, Aspira Scientific, Abnova, Abcam and Abbexa Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Prostacyclin (PGI2) ELISA Kits market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Prostacyclin (PGI2) ELISA Kits and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Prostacyclin (PGI2) ELISA Kits sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Prostacyclin (PGI2) ELISA Kits market size, projected growth trends, production technologies, key applications, and end-use industries.

Prostacyclin (PGI2) ELISA Kits Segment by Company

United States Biological

Fitzgerald Industries International

Enzo Life Sciences

Biomatik Corporation

Aspira Scientific

Abnova

Abcam

Abbexa Ltd

Prostacyclin (PGI2) ELISA Kits Segment by Type

Plasma

Serum

Other Biological Fluid

Prostacyclin (PGI2) ELISA Kits Segment by Application

Laboratories

Hospitals

Prostacyclin (PGI2) ELISA Kits Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Prostacyclin (PGI2) ELISA Kits status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Prostacyclin (PGI2) ELISA Kits market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Prostacyclin (PGI2) ELISA Kits significant trends, drivers, influence factors in global and regions.

6. To analyze Prostacyclin (PGI2) ELISA Kits competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prostacyclin (PGI2) ELISA Kits market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Prostacyclin (PGI2) ELISA Kits and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prostacyclin (PGI2) ELISA Kits.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Prostacyclin (PGI2) ELISA Kits market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Prostacyclin (PGI2) ELISA Kits industry.

Chapter 3: Detailed analysis of Prostacyclin (PGI2) ELISA Kits manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Prostacyclin (PGI2) ELISA Kits in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Prostacyclin (PGI2) ELISA Kits in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Prostacyclin (PGI2) ELISA Kits Industry Trends Table 2. Prostacyclin (PGI2) ELISA Kits Industry Drivers Table 3. Prostacyclin (PGI2) ELISA Kits Industry Opportunities and Challenges Table 4. Prostacyclin (PGI2) ELISA Kits Industry Restraints Table 5. Global Prostacyclin (PGI2) ELISA Kits Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Prostacyclin (PGI2) ELISA Kits Revenue Share by Company (2021-2026) Table 7. Global Prostacyclin (PGI2) ELISA Kits Sales Volume by Company (k units) & (2021-2026) Table 8. Global Prostacyclin (PGI2) ELISA Kits Sales Volume Share by Company (2021-2026) Table 9. Global Prostacyclin (PGI2) ELISA Kits Average Price (US$/unit) of Company (2021-2026) Table 10. Global Prostacyclin (PGI2) ELISA Kits Company Ranking, (2024-2026) & (USD Million) Table 11. Global Prostacyclin (PGI2) ELISA Kits Key Company Manufacturing Base & Headquarters Table 12. Global Prostacyclin (PGI2) ELISA Kits Company, Product Type & Application Table 13. Global Prostacyclin (PGI2) ELISA Kits Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Prostacyclin (PGI2) ELISA Kits by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Plasma Table 18. Significant Companies of Serum Table 19. Significant Companies of Other Biological Fluid Table 20. Global Prostacyclin (PGI2) ELISA Kits Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Prostacyclin (PGI2) ELISA Kits Sales Volume by Type (2021-2026) & (k units) Table 22. Global Prostacyclin (PGI2) ELISA Kits Sales Volume by Type (2027-2032) & (k units) Table 23. Global Prostacyclin (PGI2) ELISA Kits Sales Volume Share by Type (2021-2026) Table 24. Global Prostacyclin (PGI2) ELISA Kits Sales Volume Share by Type (2027-2032) Table 25. Global Prostacyclin (PGI2) ELISA Kits Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Prostacyclin (PGI2) ELISA Kits Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Prostacyclin (PGI2) ELISA Kits Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Prostacyclin (PGI2) ELISA Kits Sales Value Share by Type (2021-2026) Table 29. Global Prostacyclin (PGI2) ELISA Kits Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Laboratories Table 31. Significant Companies of Hospitals Table 32. Global Prostacyclin (PGI2) ELISA Kits Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Prostacyclin (PGI2) ELISA Kits Sales Volume by Application (2021-2026) & (k units) Table 34. Global Prostacyclin (PGI2) ELISA Kits Sales Volume by Application (2027-2032) & (k units) Table 35. Global Prostacyclin (PGI2) ELISA Kits Sales Volume Share by Application (2021-2026) Table 36. Global Prostacyclin (PGI2) ELISA Kits Sales Volume Share by Application (2027-2032) Table 37. Global Prostacyclin (PGI2) ELISA Kits Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Prostacyclin (PGI2) ELISA Kits Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Prostacyclin (PGI2) ELISA Kits Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Prostacyclin (PGI2) ELISA Kits Sales Value Share by Application (2021-2026) Table 41. Global Prostacyclin (PGI2) ELISA Kits Sales Value Share by Application (2027-2032) Table 42. Global Prostacyclin (PGI2) ELISA Kits Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Prostacyclin (PGI2) ELISA Kits Sales by Region (2021-2026) & (k units) Table 44. Global Prostacyclin (PGI2) ELISA Kits Sales Market Share by Region (2021-2026) Table 45. Global Prostacyclin (PGI2) ELISA Kits Sales by Region (2027-2032) & (k units) Table 46. Global Prostacyclin (PGI2) ELISA Kits Sales Market Share by Region (2027-2032) Table 47. Global Prostacyclin (PGI2) ELISA Kits Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Prostacyclin (PGI2) ELISA Kits Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Prostacyclin (PGI2) ELISA Kits Sales Value Share by Region (2021-2026) Table 50. Global Prostacyclin (PGI2) ELISA Kits Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Prostacyclin (PGI2) ELISA Kits Sales Value Share by Region (2027-2032) Table 52. Global Prostacyclin (PGI2) ELISA Kits Market Average Price (US$/unit) by Region (2021-2026) Table 53. Global Prostacyclin (PGI2) ELISA Kits Market Average Price (US$/unit) by Region (2027-2032) Table 54. Global Prostacyclin (PGI2) ELISA Kits Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Global Prostacyclin (PGI2) ELISA Kits Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Prostacyclin (PGI2) ELISA Kits Sales by Country (2021-2026) & (k units) Table 57. Global Prostacyclin (PGI2) ELISA Kits Sales Market Share by Country (2021-2026) Table 58. Global Prostacyclin (PGI2) ELISA Kits Sales by Country (2027-2032) & (k units) Table 59. Global Prostacyclin (PGI2) ELISA Kits Sales Market Share by Country (2027-2032) Table 60. Global Prostacyclin (PGI2) ELISA Kits Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Prostacyclin (PGI2) ELISA Kits Sales Value Market Share by Country (2021-2026) Table 62. Global Prostacyclin (PGI2) ELISA Kits Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Prostacyclin (PGI2) ELISA Kits Sales Value Market Share by Country (2027-2032) Table 64. United States Biological Company Information Table 65. United States Biological Business Overview Table 66. United States Biological Prostacyclin (PGI2) ELISA Kits Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 67. United States Biological Prostacyclin (PGI2) ELISA Kits Product Portfolio Table 68. United States Biological Recent Development Table 69. Fitzgerald Industries International Company Information Table 70. Fitzgerald Industries International Business Overview Table 71. Fitzgerald Industries International Prostacyclin (PGI2) ELISA Kits Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 72. Fitzgerald Industries International Prostacyclin (PGI2) ELISA Kits Product Portfolio Table 73. Fitzgerald Industries International Recent Development Table 74. Enzo Life Sciences Company Information Table 75. Enzo Life Sciences Business Overview Table 76. Enzo Life Sciences Prostacyclin (PGI2) ELISA Kits Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. Enzo Life Sciences Prostacyclin (PGI2) ELISA Kits Product Portfolio Table 78. Enzo Life Sciences Recent Development Table 79. Biomatik Corporation Company Information Table 80. Biomatik Corporation Business Overview Table 81. Biomatik Corporation Prostacyclin (PGI2) ELISA Kits Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. Biomatik Corporation Prostacyclin (PGI2) ELISA Kits Product Portfolio Table 83. Biomatik Corporation Recent Development Table 84. Aspira Scientific Company Information Table 85. Aspira Scientific Business Overview Table 86. Aspira Scientific Prostacyclin (PGI2) ELISA Kits Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. Aspira Scientific Prostacyclin (PGI2) ELISA Kits Product Portfolio Table 88. Aspira Scientific Recent Development Table 89. Abnova Company Information Table 90. Abnova Business Overview Table 91. Abnova Prostacyclin (PGI2) ELISA Kits Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. Abnova Prostacyclin (PGI2) ELISA Kits Product Portfolio Table 93. Abnova Recent Development Table 94. Abcam Company Information Table 95. Abcam Business Overview Table 96. Abcam Prostacyclin (PGI2) ELISA Kits Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 97. Abcam Prostacyclin (PGI2) ELISA Kits Product Portfolio Table 98. Abcam Recent Development Table 99. Abbexa Ltd Company Information Table 100. Abbexa Ltd Business Overview Table 101. Abbexa Ltd Prostacyclin (PGI2) ELISA Kits Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 102. Abbexa Ltd Prostacyclin (PGI2) ELISA Kits Product Portfolio Table 103. Abbexa Ltd Recent Development Table 104. Key Raw Materials Table 105. Raw Materials Key Suppliers Table 106. Prostacyclin (PGI2) ELISA Kits Distributors List Table 107. Prostacyclin (PGI2) ELISA Kits Customers List Table 108. Research Programs/Design for This Report Table 109. Authors List of This Report Table 110. Secondary Sources Table 111. Primary Sources List of Figures Figure 1. Prostacyclin (PGI2) ELISA Kits Product Image Figure 2. Global Prostacyclin (PGI2) ELISA Kits Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Prostacyclin (PGI2) ELISA Kits Sales Value (2021-2032) & (US$ Million) Figure 4. Global Prostacyclin (PGI2) ELISA Kits Sales (2021-2032) & (k units) Figure 5. Global Prostacyclin (PGI2) ELISA Kits Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Prostacyclin (PGI2) ELISA Kits Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Plasma Image Figure 10. Serum Image Figure 11. Other Biological Fluid Image Figure 12. Global Prostacyclin (PGI2) ELISA Kits Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Prostacyclin (PGI2) ELISA Kits Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Prostacyclin (PGI2) ELISA Kits Sales Volume Share by Type (2021-2032) Figure 15. Global Prostacyclin (PGI2) ELISA Kits Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Prostacyclin (PGI2) ELISA Kits Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Prostacyclin (PGI2) ELISA Kits Sales Value Share by Type (2021-2032) Figure 18. Laboratories Image Figure 19. Hospitals Image Figure 20. Global Prostacyclin (PGI2) ELISA Kits Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Prostacyclin (PGI2) ELISA Kits Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Prostacyclin (PGI2) ELISA Kits Sales Volume Share by Application (2021-2032) Figure 23. Global Prostacyclin (PGI2) ELISA Kits Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Prostacyclin (PGI2) ELISA Kits Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Prostacyclin (PGI2) ELISA Kits Sales Value Share by Application (2021-2032) Figure 26. Global Prostacyclin (PGI2) ELISA Kits Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 27. Global Prostacyclin (PGI2) ELISA Kits Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Prostacyclin (PGI2) ELISA Kits Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Prostacyclin (PGI2) ELISA Kits Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Prostacyclin (PGI2) ELISA Kits Sales Value (2021-2032) & (US$ Million) Figure 31. North America Prostacyclin (PGI2) ELISA Kits Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Prostacyclin (PGI2) ELISA Kits Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Prostacyclin (PGI2) ELISA Kits Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Prostacyclin (PGI2) ELISA Kits Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Prostacyclin (PGI2) ELISA Kits Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Prostacyclin (PGI2) ELISA Kits Sales Value (2021-2032) & (US$ Million) Figure 37. South America Prostacyclin (PGI2) ELISA Kits Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Prostacyclin (PGI2) ELISA Kits Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Prostacyclin (PGI2) ELISA Kits Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Prostacyclin (PGI2) ELISA Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Prostacyclin (PGI2) ELISA Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Prostacyclin (PGI2) ELISA Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Prostacyclin (PGI2) ELISA Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Prostacyclin (PGI2) ELISA Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Prostacyclin (PGI2) ELISA Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Prostacyclin (PGI2) ELISA Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Prostacyclin (PGI2) ELISA Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Prostacyclin (PGI2) ELISA Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Prostacyclin (PGI2) ELISA Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Prostacyclin (PGI2) ELISA Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Prostacyclin (PGI2) ELISA Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Prostacyclin (PGI2) ELISA Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Prostacyclin (PGI2) ELISA Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Prostacyclin (PGI2) ELISA Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Prostacyclin (PGI2) ELISA Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Prostacyclin (PGI2) ELISA Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Prostacyclin (PGI2) ELISA Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Prostacyclin (PGI2) ELISA Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Prostacyclin (PGI2) ELISA Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Prostacyclin (PGI2) ELISA Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Prostacyclin (PGI2) ELISA Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Prostacyclin (PGI2) ELISA Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Prostacyclin (PGI2) ELISA Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Prostacyclin (PGI2) ELISA Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Prostacyclin (PGI2) ELISA Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Prostacyclin (PGI2) ELISA Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Prostacyclin (PGI2) ELISA Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Prostacyclin (PGI2) ELISA Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Prostacyclin (PGI2) ELISA Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Prostacyclin (PGI2) ELISA Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Prostacyclin (PGI2) ELISA Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Prostacyclin (PGI2) ELISA Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Prostacyclin (PGI2) ELISA Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Prostacyclin (PGI2) ELISA Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Prostacyclin (PGI2) ELISA Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Prostacyclin (PGI2) ELISA Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Prostacyclin (PGI2) ELISA Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Prostacyclin (PGI2) ELISA Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Prostacyclin (PGI2) ELISA Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Prostacyclin (PGI2) ELISA Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Prostacyclin (PGI2) ELISA Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Prostacyclin (PGI2) ELISA Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Prostacyclin (PGI2) ELISA Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Prostacyclin (PGI2) ELISA Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Prostacyclin (PGI2) ELISA Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Prostacyclin (PGI2) ELISA Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Prostacyclin (PGI2) ELISA Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Prostacyclin (PGI2) ELISA Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Prostacyclin (PGI2) ELISA Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Prostacyclin (PGI2) ELISA Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Prostacyclin (PGI2) ELISA Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Prostacyclin (PGI2) ELISA Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Prostacyclin (PGI2) ELISA Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Prostacyclin (PGI2) ELISA Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Prostacyclin (PGI2) ELISA Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Prostacyclin (PGI2) ELISA Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Prostacyclin (PGI2) ELISA Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Prostacyclin (PGI2) ELISA Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Prostacyclin (PGI2) ELISA Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Prostacyclin (PGI2) ELISA Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Prostacyclin (PGI2) ELISA Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Prostacyclin (PGI2) ELISA Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Prostacyclin (PGI2) ELISA Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Prostacyclin (PGI2) ELISA Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Prostacyclin (PGI2) ELISA Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Prostacyclin (PGI2) ELISA Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Prostacyclin (PGI2) ELISA Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Prostacyclin (PGI2) ELISA Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Prostacyclin (PGI2) ELISA Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Prostacyclin (PGI2) ELISA Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Prostacyclin (PGI2) ELISA Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Prostacyclin (PGI2) ELISA Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Prostacyclin (PGI2) ELISA Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Prostacyclin (PGI2) ELISA Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Prostacyclin (PGI2) ELISA Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Prostacyclin (PGI2) ELISA Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Prostacyclin (PGI2) ELISA Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Prostacyclin (PGI2) ELISA Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Prostacyclin (PGI2) ELISA Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Prostacyclin (PGI2) ELISA Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Prostacyclin (PGI2) ELISA Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Prostacyclin (PGI2) ELISA Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Prostacyclin (PGI2) ELISA Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Prostacyclin (PGI2) ELISA Kits Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Prostacyclin (PGI2) ELISA Kits Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Plasma
  • Serum
  • Other Biological Fluid
Applications
  • Laboratories
  • Hospitals
Companies covered
  • United States Biological
  • Fitzgerald Industries International
  • Enzo Life Sciences
  • Biomatik Corporation
  • Aspira Scientific
  • Abnova
  • Abcam
  • Abbexa Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Prostacyclin (PGI2) ELISA Kits Sales Value (2021-2032)
  4. 1.2.2 Global Prostacyclin (PGI2) ELISA Kits Sales Volume (2021-2032)
  5. 1.2.3 Global Prostacyclin (PGI2) ELISA Kits Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Prostacyclin (PGI2) ELISA Kits Market Dynamics
  1. 2.1 Prostacyclin (PGI2) ELISA Kits Industry Trends
  2. 2.2 Prostacyclin (PGI2) ELISA Kits Industry Drivers
  3. 2.3 Prostacyclin (PGI2) ELISA Kits Industry Opportunities and Challenges
  4. 2.4 Prostacyclin (PGI2) ELISA Kits Industry Restraints
3 Prostacyclin (PGI2) ELISA Kits Market by Company
  1. 3.1 Global Prostacyclin (PGI2) ELISA Kits Company Revenue Ranking in 2025
  2. 3.2 Global Prostacyclin (PGI2) ELISA Kits Revenue by Company (2021-2026)
  3. 3.3 Global Prostacyclin (PGI2) ELISA Kits Sales Volume by Company (2021-2026)
  4. 3.4 Global Prostacyclin (PGI2) ELISA Kits Average Price by Company (2021-2026)
  5. 3.5 Global Prostacyclin (PGI2) ELISA Kits Company Ranking (2024-2026)
  6. 3.6 Global Prostacyclin (PGI2) ELISA Kits Company Manufacturing Base and Headquarters
  7. 3.7 Global Prostacyclin (PGI2) ELISA Kits Company Product Type and Application
  8. 3.8 Global Prostacyclin (PGI2) ELISA Kits Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Prostacyclin (PGI2) ELISA Kits Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Prostacyclin (PGI2) ELISA Kits Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Prostacyclin (PGI2) ELISA Kits Market by Type
  1. 4.1 Prostacyclin (PGI2) ELISA Kits Type Introduction
  2. 4.1.1 Plasma
  3. 4.1.2 Serum
  4. 4.1.3 Other Biological Fluid
  5. 4.2 Global Prostacyclin (PGI2) ELISA Kits Sales Volume by Type
  6. 4.2.1 Global Prostacyclin (PGI2) ELISA Kits Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Prostacyclin (PGI2) ELISA Kits Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Prostacyclin (PGI2) ELISA Kits Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Prostacyclin (PGI2) ELISA Kits Sales Value by Type
  10. 4.3.1 Global Prostacyclin (PGI2) ELISA Kits Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Prostacyclin (PGI2) ELISA Kits Sales Value by Type (2021-2032)
  12. 4.3.3 Global Prostacyclin (PGI2) ELISA Kits Sales Value Share by Type (2021-2032)
5 Prostacyclin (PGI2) ELISA Kits Market by Application
  1. 5.1 Prostacyclin (PGI2) ELISA Kits Application Introduction
  2. 5.1.1 Laboratories
  3. 5.1.2 Hospitals
  4. 5.2 Global Prostacyclin (PGI2) ELISA Kits Sales Volume by Application
  5. 5.2.1 Global Prostacyclin (PGI2) ELISA Kits Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Prostacyclin (PGI2) ELISA Kits Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Prostacyclin (PGI2) ELISA Kits Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Prostacyclin (PGI2) ELISA Kits Sales Value by Application
  9. 5.3.1 Global Prostacyclin (PGI2) ELISA Kits Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Prostacyclin (PGI2) ELISA Kits Sales Value by Application (2021-2032)
  11. 5.3.3 Global Prostacyclin (PGI2) ELISA Kits Sales Value Share by Application (2021-2032)
6 Prostacyclin (PGI2) ELISA Kits Regional Sales and Value Analysis
  1. 6.1 Global Prostacyclin (PGI2) ELISA Kits Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Prostacyclin (PGI2) ELISA Kits Sales by Region (2021-2032)
  3. 6.2.1 Global Prostacyclin (PGI2) ELISA Kits Sales by Region: 2021-2026
  4. 6.2.2 Global Prostacyclin (PGI2) ELISA Kits Sales by Region (2027-2032)
  5. 6.3 Global Prostacyclin (PGI2) ELISA Kits Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Prostacyclin (PGI2) ELISA Kits Sales Value by Region (2021-2032)
  7. 6.4.1 Global Prostacyclin (PGI2) ELISA Kits Sales Value by Region: 2021-2026
  8. 6.4.2 Global Prostacyclin (PGI2) ELISA Kits Sales Value by Region (2027-2032)
  9. 6.5 Global Prostacyclin (PGI2) ELISA Kits Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Prostacyclin (PGI2) ELISA Kits Sales Value (2021-2032)
  12. 6.6.2 North America Prostacyclin (PGI2) ELISA Kits Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Prostacyclin (PGI2) ELISA Kits Sales Value (2021-2032)
  15. 6.7.2 Europe Prostacyclin (PGI2) ELISA Kits Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Prostacyclin (PGI2) ELISA Kits Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Prostacyclin (PGI2) ELISA Kits Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Prostacyclin (PGI2) ELISA Kits Sales Value (2021-2032)
  21. 6.9.2 South America Prostacyclin (PGI2) ELISA Kits Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Prostacyclin (PGI2) ELISA Kits Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Prostacyclin (PGI2) ELISA Kits Sales Value Share by Country, 2025 VS 2032
7 Prostacyclin (PGI2) ELISA Kits Country-level Sales and Value Analysis
  1. 7.1 Global Prostacyclin (PGI2) ELISA Kits Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Prostacyclin (PGI2) ELISA Kits Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Prostacyclin (PGI2) ELISA Kits Sales by Country (2021-2032)
  4. 7.3.1 Global Prostacyclin (PGI2) ELISA Kits Sales by Country (2021-2026)
  5. 7.3.2 Global Prostacyclin (PGI2) ELISA Kits Sales by Country (2027-2032)
  6. 7.4 Global Prostacyclin (PGI2) ELISA Kits Sales Value by Country (2021-2032)
  7. 7.4.1 Global Prostacyclin (PGI2) ELISA Kits Sales Value by Country (2021-2026)
  8. 7.4.2 Global Prostacyclin (PGI2) ELISA Kits Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Prostacyclin (PGI2) ELISA Kits Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Prostacyclin (PGI2) ELISA Kits Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Prostacyclin (PGI2) ELISA Kits Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Prostacyclin (PGI2) ELISA Kits Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Prostacyclin (PGI2) ELISA Kits Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Prostacyclin (PGI2) ELISA Kits Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Prostacyclin (PGI2) ELISA Kits Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Prostacyclin (PGI2) ELISA Kits Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Prostacyclin (PGI2) ELISA Kits Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Prostacyclin (PGI2) ELISA Kits Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Prostacyclin (PGI2) ELISA Kits Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Prostacyclin (PGI2) ELISA Kits Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Prostacyclin (PGI2) ELISA Kits Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Prostacyclin (PGI2) ELISA Kits Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Prostacyclin (PGI2) ELISA Kits Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Prostacyclin (PGI2) ELISA Kits Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Prostacyclin (PGI2) ELISA Kits Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Prostacyclin (PGI2) ELISA Kits Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Prostacyclin (PGI2) ELISA Kits Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Prostacyclin (PGI2) ELISA Kits Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Prostacyclin (PGI2) ELISA Kits Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Prostacyclin (PGI2) ELISA Kits Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Prostacyclin (PGI2) ELISA Kits Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Prostacyclin (PGI2) ELISA Kits Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Prostacyclin (PGI2) ELISA Kits Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Prostacyclin (PGI2) ELISA Kits Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Prostacyclin (PGI2) ELISA Kits Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Prostacyclin (PGI2) ELISA Kits Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Prostacyclin (PGI2) ELISA Kits Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Prostacyclin (PGI2) ELISA Kits Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Prostacyclin (PGI2) ELISA Kits Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Prostacyclin (PGI2) ELISA Kits Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Prostacyclin (PGI2) ELISA Kits Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Prostacyclin (PGI2) ELISA Kits Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Prostacyclin (PGI2) ELISA Kits Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Prostacyclin (PGI2) ELISA Kits Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Prostacyclin (PGI2) ELISA Kits Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Prostacyclin (PGI2) ELISA Kits Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Prostacyclin (PGI2) ELISA Kits Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Prostacyclin (PGI2) ELISA Kits Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Prostacyclin (PGI2) ELISA Kits Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Prostacyclin (PGI2) ELISA Kits Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Prostacyclin (PGI2) ELISA Kits Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Prostacyclin (PGI2) ELISA Kits Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Prostacyclin (PGI2) ELISA Kits Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Prostacyclin (PGI2) ELISA Kits Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Prostacyclin (PGI2) ELISA Kits Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Prostacyclin (PGI2) ELISA Kits Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Prostacyclin (PGI2) ELISA Kits Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Prostacyclin (PGI2) ELISA Kits Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Prostacyclin (PGI2) ELISA Kits Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Prostacyclin (PGI2) ELISA Kits Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Prostacyclin (PGI2) ELISA Kits Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Prostacyclin (PGI2) ELISA Kits Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Prostacyclin (PGI2) ELISA Kits Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Prostacyclin (PGI2) ELISA Kits Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Prostacyclin (PGI2) ELISA Kits Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Prostacyclin (PGI2) ELISA Kits Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Prostacyclin (PGI2) ELISA Kits Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Prostacyclin (PGI2) ELISA Kits Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Prostacyclin (PGI2) ELISA Kits Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Prostacyclin (PGI2) ELISA Kits Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Prostacyclin (PGI2) ELISA Kits Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Prostacyclin (PGI2) ELISA Kits Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Prostacyclin (PGI2) ELISA Kits Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Prostacyclin (PGI2) ELISA Kits Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Prostacyclin (PGI2) ELISA Kits Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Prostacyclin (PGI2) ELISA Kits Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Prostacyclin (PGI2) ELISA Kits Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Prostacyclin (PGI2) ELISA Kits Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Prostacyclin (PGI2) ELISA Kits Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Prostacyclin (PGI2) ELISA Kits Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Prostacyclin (PGI2) ELISA Kits Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Prostacyclin (PGI2) ELISA Kits Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Prostacyclin (PGI2) ELISA Kits Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Prostacyclin (PGI2) ELISA Kits Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Prostacyclin (PGI2) ELISA Kits Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Prostacyclin (PGI2) ELISA Kits Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Prostacyclin (PGI2) ELISA Kits Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Prostacyclin (PGI2) ELISA Kits Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Prostacyclin (PGI2) ELISA Kits Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Prostacyclin (PGI2) ELISA Kits Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Prostacyclin (PGI2) ELISA Kits Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Prostacyclin (PGI2) ELISA Kits Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 United States Biological
  2. 8.1.1 United States Biological Company Information
  3. 8.1.2 United States Biological Business Overview
  4. 8.1.3 United States Biological Prostacyclin (PGI2) ELISA Kits Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 United States Biological Prostacyclin (PGI2) ELISA Kits Product Portfolio
  6. 8.1.5 United States Biological Recent Developments
  7. 8.2 Fitzgerald Industries International
  8. 8.2.1 Fitzgerald Industries International Company Information
  9. 8.2.2 Fitzgerald Industries International Business Overview
  10. 8.2.3 Fitzgerald Industries International Prostacyclin (PGI2) ELISA Kits Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Fitzgerald Industries International Prostacyclin (PGI2) ELISA Kits Product Portfolio
  12. 8.2.5 Fitzgerald Industries International Recent Developments
  13. 8.3 Enzo Life Sciences
  14. 8.3.1 Enzo Life Sciences Company Information
  15. 8.3.2 Enzo Life Sciences Business Overview
  16. 8.3.3 Enzo Life Sciences Prostacyclin (PGI2) ELISA Kits Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Enzo Life Sciences Prostacyclin (PGI2) ELISA Kits Product Portfolio
  18. 8.3.5 Enzo Life Sciences Recent Developments
  19. 8.4 Biomatik Corporation
  20. 8.4.1 Biomatik Corporation Company Information
  21. 8.4.2 Biomatik Corporation Business Overview
  22. 8.4.3 Biomatik Corporation Prostacyclin (PGI2) ELISA Kits Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Biomatik Corporation Prostacyclin (PGI2) ELISA Kits Product Portfolio
  24. 8.4.5 Biomatik Corporation Recent Developments
  25. 8.5 Aspira Scientific
  26. 8.5.1 Aspira Scientific Company Information
  27. 8.5.2 Aspira Scientific Business Overview
  28. 8.5.3 Aspira Scientific Prostacyclin (PGI2) ELISA Kits Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Aspira Scientific Prostacyclin (PGI2) ELISA Kits Product Portfolio
  30. 8.5.5 Aspira Scientific Recent Developments
  31. 8.6 Abnova
  32. 8.6.1 Abnova Company Information
  33. 8.6.2 Abnova Business Overview
  34. 8.6.3 Abnova Prostacyclin (PGI2) ELISA Kits Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Abnova Prostacyclin (PGI2) ELISA Kits Product Portfolio
  36. 8.6.5 Abnova Recent Developments
  37. 8.7 Abcam
  38. 8.7.1 Abcam Company Information
  39. 8.7.2 Abcam Business Overview
  40. 8.7.3 Abcam Prostacyclin (PGI2) ELISA Kits Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Abcam Prostacyclin (PGI2) ELISA Kits Product Portfolio
  42. 8.7.5 Abcam Recent Developments
  43. 8.8 Abbexa Ltd
  44. 8.8.1 Abbexa Ltd Company Information
  45. 8.8.2 Abbexa Ltd Business Overview
  46. 8.8.3 Abbexa Ltd Prostacyclin (PGI2) ELISA Kits Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Abbexa Ltd Prostacyclin (PGI2) ELISA Kits Product Portfolio
  48. 8.8.5 Abbexa Ltd Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Prostacyclin (PGI2) ELISA Kits Value Chain Analysis
  2. 9.1.1 Prostacyclin (PGI2) ELISA Kits Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Prostacyclin (PGI2) ELISA Kits Sales Mode & Process
  6. 9.2 Prostacyclin (PGI2) ELISA Kits Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Prostacyclin (PGI2) ELISA Kits Distributors
  9. 9.2.3 Prostacyclin (PGI2) ELISA Kits Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst